Latest CanVECTOR News
 

Upcoming Events

Tuesday, May 28, 2024 at 11:00 AM
Duration: 1 hour

National Thrombosis Seminar: Anticoagulant and Antiplatelet Prescribing in 2024: When Less is More

Featuring:  Geoffrey Barnes, MD, MSc - University of Michigan Jordan Schaefer, MD - University of Michigan Learning Objectives: Compare the risks and benefits of different antithro...

Clot+ Articles

Clot+ Articles RSS Feed
Obese patients with atrial fibrillation are more efficiently protected from thrombosis under warfarin or xabans compared to non-obese patients; a systematic review and Meta-analysis of six randomized controlled trials.
May 11, 2024
Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients.
May 11, 2024

Twitter